Sevopramide

This classification denotes a muscle relaxant with the molecular formula C29H43N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 18USM69UB1, chemically known as benzenepropanamide, alpha-(benzoylamino)-4-(3-(diethylamino)propoxy)-n,n-dipropyl- but generally known as sevopramide, which bears US NIH Compound Identifier 210325. European Medicines Agency schedules Sevopramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10507MIG. The term SEVOPRAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). SEVOPRAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sevopramide under HS 29242995 and SITC 51479. As of Q4 2014, SEVOPRAMIDE remains the US FDA Preferred Term for this commodity. Sevopramide bears US NLM identifiers UMLS ID C2699293 and NCI Concept Code C76775. SMILES: O(CCCN(CC)CC)c1ccc(CC(NC(=O)c2ccccc2)C(=O)N(CCC)CCC)cc1.